gilteritinib
astellas
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
#eha2023 | mark levis presents ph3 morpho results of flt3 inhibitor gilteritinib as post-hct maintenance for flt3-itd #aml. primary outcome of rfs was not met (hr=0.679; p=0.0518) however gilteritinib had more pronounced effect in pts with detectable mrd
#leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm